JNJ-63623872

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for JNJ-63623872, covering 2015-09-22 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation [Phase 1]

See pricing